About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

SYMBICORT® in the Treatment of COPD

NCT00564499·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

patients (m/f) with COPD (GOLD stadium III and IV)

You may not be if

patients who recently quit smoking (\<3months)

The record

StatusCompleted

PhaseNo phase

Taking part—

StartedMar 2006

UpdatedJan 28, 2011

Conditions

Clareo Health | SYMBICORT® in the Treatment of COPD